According to Vertex Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is S$14.74 Billion. an increase over the revenue in the year 2023 that were of S$13.03 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | S$14.97 B | 14.92% |
2023 | S$13.03 B | 8.87% |
2022 | S$11.97 B | 16.92% |
2021 | S$10.23 B | 24.73% |
2020 | S$8.20 B | 46.28% |
2019 | S$5.61 B | 34.8% |
2018 | S$4.16 B | 25.08% |
2017 | S$3.32 B | 35.11% |
2016 | S$2.46 B | 68.71% |
2015 | S$1.46 B | 90.41% |
2014 | S$0.76 B | -50.06% |
2013 | S$1.53 B | -17.77% |
2012 | S$1.86 B | 2.22% |
2011 | S$1.82 B | 889.2% |
2010 | S$0.18 B | 29.11% |
2009 | S$0.14 B | -43.01% |
2008 | S$0.25 B | -12.36% |
2007 | S$0.28 B | -13.68% |
2006 | S$0.33 B | 23.85% |
2005 | S$0.26 B | 59.86% |
2004 | S$0.16 B | 48.07% |
2003 | S$0.11 B | -59.51% |
2002 | S$0.27 B | 14.04% |
2001 | S$0.24 B | 79.6% |
2000 | S$0.13 B | 53.72% |
1999 | S$88.77 M | 32.76% |
1998 | S$66.86 M | -9.45% |
1997 | S$73.84 M | 296.74% |
1996 | S$18.61 M |